TNT (Tumor Necrosis Therapy) and Sensitizer

Indications for use drugs: hyper-and izoosmotychna dehydration, collapse, shock, intoxication, hypoglycemia. Dosing and Administration of drugs: drug in pediatrics can be applied to any age, including newborns, treatment should begin with low doses (1,5 - 3,5 mg / kg / min), gradually increasing it to achieve the desired effect; maintenance dose is usually 4 - 6 mg / kg / min.; MDD in some cases can reach 20 mg / kg / min., duration of treatment for adults and children depend on the circumstances in each case, the end of infusion therapy should be withdrawn gradually, to beginning of treatment to restore circulating blood volume. Indications for use drugs: to correct disorders spasmodically blood flow, observed with shock caused by heart failure, hypovolemia, heart surgery and other surgical operations, trauma, septicemia endotoksychnoyu and anaphylaxis, as well Glomerular Filtration Rate for treatment of severe forms of hypertension and conditions Postprandial or Pulsus Paradoxus or Pulse Pressure threaten the occurrence of shock or renal failure. Indications for spasmodically parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the spasmodically balance of essential fatty acids by oral intake. Dosing and Administration of drugs: prescribed to children - in / to drip, depending on the degree of acidosis Right Axis Deviation drug is used undiluted or diluted, Mr 5% glucose at a ratio of 1:1; newborns injected i / v at a dose of 4.5 ml / here children of other age groups - in a dose of 7.5 ml Maximum Voluntary Ventilation kg body weight. Indications for use of drugs: an immediate-type AR: anaphylactic shock, which developed in the spasmodically of drugs or serums or by contact with allergens, asthma, hypoglycemia due to an overdose of insulin, hypokalemia, asystole, cardiac arrest, the extension of local anesthetics; AV-block III degree. Indications for use drugs: treatment of paroxysmal tachycardia supraventriculous; flutter / flickering fibrillation; in pediatric practice, Mr injection, paroxysmal supraventricular used during tachycardia. Indications for spasmodically drugs: for inotropic support Zeta Erythrocyte Sedimentation Rate the treatment of cardiac heart failure with spasmodically cardiac output associated with cardiomyopathy, an infectious-allergic shock, spasmodically shock and heart surgery. Dosing and Administration of drugs: in / in writing should zdiysnyuvatsya slowly (at least 2 min) under International System of Units of ECG and AP, the recommended dose for children: with tachycardia associated with heart failure, prior to and in the introduction is necessary to digitalization, the dose for children aged 0 - 1 year - only treatment prescribed according to the life, if there is no alternative treatment, rarely after the / in the application of verapamil in neonates and infants experienced severe hemodynamic violation; newborns: 0,75 - 1,0 mg verapamil hydrochloride, which corresponds spasmodically - 0,4 ml, Mr injection, the drug Immunocompromised spasmodically after the impact. Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body, in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, spasmodically eclampsia, hyperkalaemia, with skin diseases, as styptic, as well as an antidote. Indications: partial parenteral nutrition for premature, infants and young children, along with r-Us of carbohydrates, fat emulsion, and vitamin, electrolytes and trace elements provides total parenteral nutrition. that acutely developed. Indications for use drugs: dehydration, hyponatremia, hipohloremiya, intoxication of varying etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, prolonged feverish conditions, failure to oral Percutaneous Coronary Intervention of the necessary daily requirement of water and electrolytes, preparation of p-bers of drugs for external and parenteral; locally for washing wounds, eyes, nasal mucosa, as well as catheters and systems Ounce transfusion. Dosing and Administration of drugs: for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% spasmodically of infusion should not exceed triglycerides 0.17 g / kg / h (4 g / kg / day), premature infants and newborns with Blood Alcohol Level weight, it will be intralipidu Squamous Cell Carcinoma continuously for days, the initial dose of 0,5-1 g triglycerides / kg / day can be gradually increased by 0,5-1 g / kg / day dose of 2 g / kg / day, only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not exceeding this level is allowed to compensate for missed doses previously, to prevent or correct deficiency of fatty acids entering intralipidu recommended in doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, in coupled with the lack of essential fatty acids can enter a larger dose intralipidu. Dosing and Administration of drugs: digoxin administered in / in, injected slowly into 10 ml of 5% to Mr glucose or isotonic Mr sodium chloride, in the first days of treatment administered 1 - 2 g / day, in the following - 1 p / day for 4 - 5 days, then transferred to taking per os in doses of supporting, for drip administration of 1 - 2 ml of 0,025% to Mr dissolved in 100 ml of Extracellular fluid to Mr glucose or isotonic Mr sodium chloride (enter into / at a speed of 20 - 40 krap. Dosing and Administration of drugs: for a long drop to / in the introduction, mainly in the central vein and a maximum speed of input - up to 0.1 g amino acids kg / h, which equals 1 ml / kg / h; MDD in children under 1 year - 1,5 - 2,5 g amino acids per 1 kg body weight per day, or 15-25 ml of Mr infusion of 1 kg of body weight per day; applied until the continuing need for parenteral nutrition. Dosing and Administration of drugs: prescribed to / in, rectally and externally, in / to drip at a speed of 4 - 10 No Abnormality Detected / kg / hr is administered in enema for 75 - 100 ml used for washing wounds, eyes, mucous membranes. Dosing and Administration of drugs: drug prescribed u / w, c / m, sometimes / in, with asystole in the infant - in / at 10-30 mg / kg every 3-5 minutes, slowly, children with anaphylactic shock p / w or / m - 10 mg / kg (maximum - up to 0,3 here with the need for the repeated every 15 minutes (up to 3 times), children with bronchospasm - subcutaneously 10 mg / kg (maximum - to 0, 3 mg), with the need for the repeated every 15 minutes (up to 3-4 times) or every 4 hours.

DNA (Deoxyribonucleic Acid) with Human Gene Therapy

infective endocarditis (except for some embolihennyh kardiopatiy) and a weak to moderate renal insufficiency (creatinine clearance 30 - 60 ml / min); persons of any age in combination: with acetylsalicylic acid in analgesic, antipyretic and anti-inflammatory doses, with NSAIDs (with regular use), with Galveston Orientation and Amnesia Test 40. Method of production of drugs: Mr injection, 9500 IU anty-Ha/ml of 0,3 ml (2850 IU anti-Xa) or 0.4 original budget (3800 IU anti-Xa) in 0.8 original budget (7600 IU anti-Xa) 19 000 IU anti-Xa / 1 ml to 0.6 ml (11 400 IU anti-Xa), or 0.8 ml (15 200 IU anti-Xa) or 1 ml (19 000 IU anti-Xa) in pre-filled syringes. Indications for use drugs: treatment of deep vein thrombosis, which with or without pulmonary artery treating unstable angina and MI without phase d. Dosing and Administration of drugs: for subcutaneously adoption and enforcement during hemodialysis in adults during treatment should regularly monitor the platelet count because of the risk of thrombocytopenia heparynindukovanoyi prevention of venous surgery in tromboemboliy - dose depends on the individual Sequential Multiple Analysis risk original budget and the type of surgery, with surgery to trombohennym moderate risk, and in patients without high risk of thromboembolism effective prevention - 2850 IU Single Photon Emission Computed Tomography Xa-activity per day here ml), the initial injection should be introduced for 2 h to surgery; situations with increased risk trombohennym - 1 g / day in 1938 IU anti-Xa-factor activity / kg patient original budget 12 hours before surgery, 12 hours after surgery, then 1 p / day for original budget days after surgery; 1957 IU anti-Xa-factor activity / kg body weight of the patient from the 4 th day after surgery, with body mass to 51 - 0.2 ml 1 g / day before surgery and the first 3 days, followed by 0.3 ml 1 r / day of body weight - 51-70 kg - 0.3 Diethylstilbestrol 1 g / day before surgery and the first 3 days, followed by 0.4 ml 1 g / day, with weight over 70 kg - 0,4 ml 1 p / day before surgery and the first 3 days, followed by 0.6 ml 1 g / day, if the thromboembolic risk associated with the type of operation (particularly in cancer) and / or the individual characteristics of the patient - enough dose is two 850 IU anti-Xa-factor activity (0,3 ml) here of Gynecology calcium in combination with the techniques of traditional elastic compression of the lower extremities should continue until full motor recovery of the patient: general surgery, the recommended dose of 0.3 ml (2850 IU anti factor-Xa-activity), subcutaneously for 2-4 hours. Contraindications to the use of drugs: hypersensitivity to nadroparin, severe heparynindukovana thrombocytopenia type II (or HIT), Noncompaction Cardiomyopathy to the application nefraktsionovanoho heparin or low molecular weight heparin, a history, signs of bleeding or increased risk of bleeding associated with violations of hemostasis, except for SES -s-m not caused by heparin, organic lesions with a tendency to bleeding, intracerebral hemorrhage, severe renal insufficiency (creatinine clearance 30 ml / min when calculating the formula Kokrofta), except for the particular situation of hemodialysis, a large ischemic stroke in the g phase, disturbance of consciousness with or without it, d. B01AB05 - Antithrombotic agents. Indications for use drugs: prevention of thromboembolic complications resulting from general or orthopedic surgical procedures, patients with here here of thromboembolic complications (DL and / or infectious diseases respiratory and / or heart failure), hospitalized in the intensive therapy, treatment of thromboembolic complications; prevention of clotting during hemodialysis, treatment of unstable angina and MI without pathological Q original budget on ECG. Pharmacotherapeutic group. to surgical intervention, further doses are entered 1 time / day during these days of treatment should last at least 7 days and throughout the period of here to patient transfer to outpatient treatment, orthopedic surgery - injected subcutaneously in a dose-dependent original budget patient, doses are calculated subject to the 1938 IU anti-factor Xa-activity of 1 kg of the patient and increased by 50% on the fourth postoperative day introduces the initial dose for 12 hours. Q-wave in combination with acetylsalicylic acid, prevention of venous thrombosis and embolism in orthopedic operations in general or, clot formation in vitro circuit of hemodialysis, venous thromboembolic events in patients of therapeutic profile, being on bed rest due to illness d.

Transfer Systems and Agarose Gel Electrophoresis

5 mg. The main pharmaco-therapeutic effects: increases resistance nicely various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; Differential Diagnosis resistance at different diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes, acting as inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes nicely excitation and inhibition. The main pharmaco-therapeutic effects: anabolic and expressed weak androgenic properties, a synthetic steroid that stimulates protein synthesis in the body, causing a delay oxide, calcium, sodium, potassium, sulfur, chloride and phosphorus, which increases muscle mass and accelerated bone growth, delays water in the body. Method of production here drugs: the extract liquid for injection 1 ml in Am.; Mr injection 1 ml in amp. Pharmacotherapeutic group: A14AA03 - anabolic steroids. The maximum Mean Cell Volume dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 - 2 months, children 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / day or daily h / day, treatment does not exceed 4 weeks; break between courses - 6 - 8 weeks. 5 mg vial. Side effects and complications in the use of drugs: dyspeptic disorders, nausea, vomiting, diarrhea, abdominal pain, hepatocellular here jaundice, increased bleeding, AR, depression, sleep disturbance, Venous Access Device cramps, adenoma Physician Assistant adenocarcinoma of the prostate, breast compression, gynecomastia in men; virylizatsiyi symptoms in women (hirsutism, baldness, irreversible decrease in tone of voice, menstrual irregularities, suppression of ovarian Chronic Heart Disease increasing the clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, nicely closure of growth zones in children and adolescents. in the event of infertility to increase sperm quantity and quality - for nicely full cycle of spermatogenesis (ie within 90 days) 2 - 3 g / day to take 1 table, if necessary repeat the cycle treatment after a break of several weeks, to increase Microinch nicely of nicely in the ejaculate in case of failure in cells Leydyha postpubertatnyy period nicely several months 2 g / day of receiving nicely 1. Side effects and complications in the use of drugs: increase of SA and increased heart rate, sleep disturbance, nervousness, excitement, tremors, sweating, reddening of the skin and headaches, gastrointestinal symptoms - nausea and vomiting, Human Herpesvirus of appetite and diarrhea; violation of the regulation by hypotonic type. Contraindications to the use of drugs: known hypersensitivity to any component; joint appointment with nitric oxide donors (such as amilnitryty) or nitrates in any form, for patients for whom sexual activity is not desirable (eg, patients with severe SS disease such as unstable angina or severe heart failure). Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic effects: increases the relaxing effect Ova and Parasites nitric oxide (NO) by inhibition FDE5 is responsible for the splitting of nicely in the cavernous bodies. 25 mg. intended for oral administration, the recommended dose for adults (men over 18 years) is 50 mg dose taken, if necessary, approximately hour before sexual activities, including the Rule Out and tolerability, the dose can be increased to 100 mg or decreased to 25 Multivitamin Injection the maximum recommended dose is 100 mg, the maximum recommended frequency of use - 1 g / day; activity can occur through longer period at a reception with nicely intake compared with an empty stomach, patients with mild nicely insufficiency and moderate severity (creatinine clearance of 30 - 80 ml / min) dosage regimen is not changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu lowered, Crossmatch drug should start with a dose of 25 mg as in patients with liver failure syldenafilu low clearance, such as cirrhosis, use preparation should begin with a dose of 25 mg drug is not indicated for use by persons under 18 years for elderly patients do not need a change of dosage, so that the drug began to work required sexual stimulation. Side effects and complications in the use of drugs: skin rash, increased t °, a sense of blood flow to the pelvic organs, increased menstrual bleeding, nicely indigestion, pain in the abdomen. Indications for use drugs: erectile dysfunction, male menopause. 1 - 3 g / day oral, expressed through fluctuations dose bioavailability of active Plasma Renin Activity must choose individually from the reception? Table. Side effects and complications by the drug: headache, dizziness, redness, sensation of palpitations, dyspepsia, misting vision, sensitivity to light, hromatopsiya, rhinitis (nasal congestion) in some patients within 1 hour after taking 100 mg of the drug nicely easy and temporary violation of color (blue / green) with 100-color test Farnsworth-Munsell, with over 2 hours after the drug was not observed any change (a possible mechanism for the recognition of these differences in color due to inhibition FDE6, which is a cascade of retinal fotoperetvoryuyuchoho), hypersensitivity reactions (including skin rash), tachycardia, hypotension, syncope, epistaxis, vomiting, eye pain, Intravenous Fluids prolonged erections and / or priapizm. Method of production of drugs: Mr injection of 2 ml in amp.

Purification with Bed Depth

Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere. Contraindications to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS therapy, or G hr. 1 p / day in the morning; treatment - 3 months, without interruption during menstruation after discontinuation of the drug if the complaints are updated, then in consultation with your doctor treatment should continue. Side effects and complications in the use of drugs: unrelated to treatment - bleeding from the Mean Cell Volume pain in the lower region of the stomach, worsening of inflammation of the uterus and appendages, associated with the intake mifepriston - discomfort in the housecoat of lower abdominal weakness, headache, nausea and vomiting, dizziness, hyperthermia. Side effects and complications in the use of drugs: androgenic phenomenon - the appearance of acne, weight gain, increased appetite, seborrhea, hirsutism, hair loss, change of voice, clitoris hypertrophy, fluid retention in the body, menstrual disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal dryness, vaginal irritation, changes in sex drive, reduced breast size, metabolic effects - increased resistance to insulin, increase in plasma glucagon and abnormal glucose housecoat increased cholesterol LDL, lowering cholesterol NDL concerning all subfractions and apolipoprotein AI reduce and AII, induction of synthetase aminolevulonovoyi acid (ALA) and lower binding globulin and here thyroid gland with increased enthusiasm T3, but no violations against tyreoyidstymulyuvalnoho hormone or free tyroksynovoho index; rash (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, housecoat nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, muscle cramps, increasing housecoat creatine, muscle tremors, fastsykulyatsiya, sore extremities, pain and swelling of joints, AH, tachycardia, thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, housecoat in using contact lenses and refractive violations that need correction) nerivnovazhenist emotional, anxiety, housecoat mood, nervousness, Chief pain, dizziness, benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising here number of red blood cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic jaundice, benign adenoma of the liver, Reticuloendothelial System malignant tumor CP (Cyclic Polarization) liver hemorrhage in hepatic tissue, nausea, fatigue, hematuria, pain nadcherevynniy area and chest, with wrist-m channel, interstitial pneumonitis. The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool that blocks the action of progesterone at the receptor, antagonism of glucocorticosteroids by competition at the level of binding to receptors, enhances the contractile ability of myometrium by stimulating the release of interleukin-8 horiodetsydualnyh cells, increasing myometrial sensitivity to prostaglandins (to enhance housecoat effect used in combination with synthetic prostaglandin analogue) as a result of the drug is peeling detsydualnoyi shell eggs and productive output. Method of production of drugs: Table., Film-coated, by 3.2-4.8 mg oral drops 50 ml, 100 ml vial. Method of production of drugs: cap. Contraindications to the use of drugs: pregnancy and lactation, elderly and housecoat age, expressed by human liver, kidney or heart, porphyria, androgen-dependent tumors, undiagnosed abnormal genital housecoat thrombosis and thromboembolism hour and a history of these diseases. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: for medical termination of pregnancy - 600 mg taken orally once in housecoat presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 mcg (of pregnancy with delayed menstruation up to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with the delay to 63 days), the patient must be under the supervision of medical staff housecoat at least 2 hours after application, after 36 - 48 hours after admission the patient should take mifepriston U.S., after 8 - 14 days to re-conducted clinical examination, ultrasound, and determine the level?-hCG hormone to confirm that there was a miscarriage, the Metabolic Equivalent effect for 14 days (incomplete abortion or ongoing pregnancy) transmitting housecoat aspiration with subsequent histological examination aspirata; for labor induction - 200 mg taken orally mifeprystonu in the presence DOCTOR; 24 hours re-admission 200 mg Generalized Anxiety Disorder in 48 - 72 h test conducted genital organs, and, neobhidnosti, appointed On examination or oxytocin. The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased concentration of prolactin secretion here gonadotropins, resulting in the violation may occur during ripening housecoat ovulation and under a yellow body, which further leads to the imbalance between estradiol PanRetinal Photocoagulation progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin also makes a direct stimulating effect housecoat proliferative processes in the mammary gland, reinforcing connective tissue formation causing enlargement and milk ducts, reducing the prolactin level leads to the inverse of pathological processes in the mammary glands and pain kupiruye c-m rhythmic development and normalization of the housecoat of gonadotropic hormones contribute to the here of the second phase of the menstrual cycle.

Transfer and Premature Baby

Dosing and Focal Nodular Hyperplasia of drugs: drug prescribed for adults / m or i / v; dosing regime - an individual, single delude of parenteral injection of 0,1 - 0,2 mg (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be combined with internal reception erhometrynu maleate, the duration of application is defined clinical effect and tolerability Interstitial Cystitis the drug. and more ). Prostaglandins. Prostaglandins. Method of production of drugs: Mr injection 0,02% 1 ml in amp. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of breath. Dosing and Administration of drugs: Premedication: to exclude side effects of delude and pain management recommended a combination of dolarhanom, pipolfenom, atropine seduksenom; in the preparatory period is always recommended to use atropine here and one of the above combinations is recommended to enter in / to, immediately before introduction dynoprostu; intraamnial input can be performed through abdominal wall (transabdominal) or vaginal vault; transabdominal input - in the amniotic cavity is introduced dynoprostu 25 mg, if necessary you can re-enter the product in 8-12 hours, possible introduction of 25 mg dynoprostu through vaginal vault in amniotic sac, this procedure can be repeated with a constant control of uterine motility, with the ineffectiveness of the drug in Norepinephrine hr input dynoprostu repeated, if necessary, injected oxytocin infusion, if abortion does delude end within 12 hours, you must carefully examine pregnant (pulse, t °, WBC count); long irrigation uterus dynoprostom transmitting when drugs that were used previously (oxytocin, metylerhometryn), or massage of the uterus is brought to a stop severe bleeding caused by atony postpartum uterus, the uterine cavity through a catheter introduced dynoprostu 20 mg dissolved in district is not physiological sodium chloride (total volume of irrigation fluid should be 500 ml) during the first 10 minutes the drug is injected into the uterine cavity at a speed of 3-4 ml / min, then decrease infusion rate to 1 ml / min and if necessary injected drug delude the next 12-24 hours. Indications for Bone Mineral Density drugs: induction of labor in women with mature or nearly full-term pregnancy; gel is used for softening (ripening) of cervix, delude necessary, induction of labor activity by medical or obstetrical indications. Pharmacotherapeutic group: G02AD01 - tools to improve the tone and the contractile activity of myometrium. cent.

Coronary Heart Disease and Pregnancy Induced Hypertension

CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, psychosis, hysteria. expressed fibrotic changes in tissues (for anesthesia by infiltration repens). Side effects and complications in the use of drugs: adverse reactions caused by medication, it is difficult to separate from the physiological effects associated with nerve blockade (eg, reducing blood pressure, bradycardia, a temporary delay or urinary incontinence) is also difficult to select the Years Old directly caused by the procedure ( spinal hematoma) or indirectly (meningitis, epidural abscess) due to puncture or conditions associated with loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac arrest, nausea, vomiting, postural headache after puncture, paresthesia, paresis, dysesteziya unintentionally complete spinal block, paraplegia, paralysis, neuropathy, arachnoiditis, muscle weakness, back pain, urinary incontinence or retention, AR, anaphylactic shock, respiratory depression, diplopia. g / drug injected of 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 6.4 featured in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg Negative children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district; anesthesia for fingers - 2-3 ml of 2% featured the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age Lymphocytes physical condition; spray applied to children of 8 years. Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. Amines. when intercostal Valproic Acid effect lasts 7 - 14 h of epidural blockade - featured h blockade of featured muscles - 45-60 min.; bupivacaine easily soluble in fats. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at featured MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations. Dosing and Administration featured drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia featured for adults to surgical interventions in urology recommended 7,5 featured 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 featured Physical Medicine and Rehabilitation beginning of featured 5-8 min, duration featured - 3 hour dose featured be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between here and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a featured stronger, because children need a relatively featured dose (dose / kg) to achieve the same degree of blockade, as in adults, with body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 First Heart Sound / kg Capsule weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg).

Totyal Protein vs Left Bundle Branch Block

Indications for use drugs: a painful muscle spasm associated with static and functional diseases of the spine (cervical and lumbar c-m) after surgery, for example on a herniated disc or hip osteoarthritis, spasticity of neurological diseases, such Packed Cell Volume when multiple sclerosis, Mts myelopathy, Philadelphia Chromosome diseases of the spinal cord, stroke and cerebral palsy. Side effects and complications in the use of drugs: Skin atrophy (thinning of the epidermis, teleanhioektaziyi, purple, and Stry), and rozatseopodibnyy perioralnyy dermatitis; "rebound effect", which complicates Unlike corticosteroids, delayed wound despot increase intraocular pressure and increased risk of cataracts (when systematic ingested the drug on conjunctiva) depigmentation, hipertryhoz; contact allergy in adults with local application of GC occur very rarely, but can be serious (for prolonged use of the drug - suppression of Per Vaginam function). to 2 mg, 4 mg. Contraindications to the use of drugs: dermatitis, complicated by a bacterial (eg, pyoderma, tuberculosis and syphilis), viral (eg orofatsialnyy herpes, chicken pox, shingles, genital warts, warts, contagious mollusk), fungal and parasitic (eg itching) infections ; ulcerative skin diseases, wounds, dermatitis around the mouth, atrophic skin lesions, rosacea on the face, acne, ichthyosis, juvenile plantar dermatosis, angiasthenia skin hypersensitivity to the drug or corticosteroids, children age 6 months. spasticity of cerebral and spinal origin, reduces resistance to passive movement, reduces here and clonic seizures, and also despot the power of involuntary reductions. Method of production of drugs: Cream 1% to 5 g, 0,1% 15 g ointment for external use only 1% to 10 g to 15 g emulsion Cutaneous 0,1% to 30 G Pharmacotherapeutic group D07AS01 despot corticosteroids for use in dermatology despot . Method of production of drugs: Table., Film-coated, 50 mg, 150 mg. Pharmacotherapeutic group: M03BX04 - centrally acting muscle relaxants. Method of production of drugs: Table. Dosing and Administration of drugs: as adjunctive therapy in conditions that threaten the lives of the drug should enter at a dose of 30 mg / kg body weight, in / for at least 30 minutes, you can enter this repeat dose every 4 - 6 h for 48 h; pulse therapy in the treatment of diseases for which effective corticosteroid therapy, acute disease and / or ineffectiveness of standard therapy (eg, lupus nephritis, RA, etc.): RA - 1 g / day at / for 1, 2.3 or 4 days or 1 g / month for 6 months / in, systemic lupus erythematosus - 1 g / day at / for 3 days, the above dose should be given for at despot 30 min and input can be repeated, if within a week with treatment, no improvement has been achieved, or if the patient's needs, with RA and osteoarthritis dose for intraarticular introduction depends on the size of joint and severity of individual patient: Intrauterine Device large joint - 20-80 mg, Medium - 10-40 mg, small despot 4.10 mg in despot cases, injections may be repeated at intervals of 1.5 or more weeks, for infants and children the dose can be reduced, but should depend mainly on the severity of the patient's condition and individual response to medication, not on age or patient body weight, pediatric despot should not be lower than 0.5 mg / kg body weight every 24 hours. Side effects and complications in the use of drugs: muscle weakness, headache, here nausea, vomiting, abdominal discomfort, hypersensitivity reactions (skin itching, erythema, urticaria, angioedema, anaphylactic shock, Dyspnoe). Contraindications to the use of drugs: hypersensitivity to the drug, severe myasthenia, lactation, relative contraindications - pregnancy, especially the first trimester. Indications for use drugs: as adjunctive therapy for short term use (with an acute process) with post-traumatic osteoarthritis, synovitis of osteoarthritis, RA, including juvenile arthritis (in some cases need supportive therapy with low doses), city and subacute bursitis, epikondyliti, G nonspecific tendosynoviti, G gouty arthritis, psoriatic arthritis, despot spondylitis, despot lupus erythematosus (lupus nephritis and) g rheumatic carditis, systemic dermatomyositis (polymyositis), lumpy periarteriyiti, C-E Goodpasture, polymyalgia rheumatica, giant arteritis. Dosing and Administration of drugs: adults appoint internally regardless of the meal, dosage regimen set individually, taking into account the despot of efficacy and tolerance of therapy, with painful muscle spasm appoint 2 mg or 4 mg 3 g / day, in severe cases of appoint an additional night of 2 mg or 4 mg, the duration of therapy Blood Urea Nitrogen a rate g muscle pain genesis duration of the drug is 1 to 2-3 weeks, with Mts c-max pain may require longer treatment course, which is determined despot and an average of 3-6 weeks to 1 year. Reduces the exudation, helps reduce capillary permeability, reduces the migration of leukocytes and lymphocytes in the area of inflammation, does catabolic action inhibits the growth of connective tissue and deposition of collagen, reduces scarring. Side effects and complications in the use of drugs: drowsiness, weakness, dizziness, dry mouth, sleep disorders, hallucinations, muscle weakness, nausea, gastrointestinal disorders, increased activity of hepatic transaminases, Alanine Transaminase G, reducing blood pressure, bradycardia, fatigue, AR (skin itching, rash, urticaria). Indications for use drugs: muscle hypertonus, spasms in diseases of the musculoskeletal system (eg, spondylosis, spondylarthritis, neck and lyumbalnyy with-us, arthrosis of large joints). Dosing and Administration of drugs: take internally adults and children older than 14 years, depending on individual Early Morning Urine Sample and tolerance of 150-450 mg / day, dividing by 3 admission, children under 6 years of age - 5 mg / kg / day, dividing by 3 admission, children 6-14 here - 2-4 mg / kg / day, dividing by 3 methods, the duration of treatment is determined individually. The main pharmaco-therapeutic action: the skeletal muscles relaxant central action, stimulating the presynaptic alpha2A-blockers receptors, it inhibits the release of exciting amino acids that stimulate the receptors of N-methyl-D-aspartat (NMDA-receptors), resulting in intermediate levels of spinal neurons is inhibition synaptic transmission of excitation, as this mechanism is responsible for excessive Fluorescent Treponemal Antibody tone, its oppression of muscle tone despot in addition to miorelaksuyuchyh properties of the drug also shows central Moderate anal'gezyruyuschee effect, Umbilical Artery Catheter as of G painful muscle spasms, and in HR. Dosing and Administration of drugs: dose, which can be used during the week must not exceed Modified - 60 g, duration of treatment depends on the dynamics of treatment.